$HDSN
HUDSON TECHNOLOGIES INC /NY

2021 Q4 Form 10-K Financial Statement

#000141057822000491 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $37.78M $192.7M $22.11M
YoY Change 70.85% 30.58% -14.14%
Cost Of Revenue $20.76M $121.1M $16.68M
YoY Change 24.43% 7.92% -20.53%
Gross Profit $17.02M $71.66M $5.430M
YoY Change 213.44% 102.38% 14.08%
Gross Profit Margin 45.06% 37.18% 24.56%
Selling, General & Admin $6.980M $26.57M $6.460M
YoY Change 8.05% -0.29% -27.09%
% of Gross Profit 41.01% 37.07% 118.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.545M $3.387M $700.0K
YoY Change 120.71% 4.73% -57.83%
% of Gross Profit 9.08% 4.73% 12.89%
Operating Expenses $7.678M $29.36M $7.180M
YoY Change 6.94% -0.5% -25.05%
Operating Profit $9.342M $42.31M -$1.750M
YoY Change -633.83% 616.55% -63.69%
Interest Expense -$2.844M $11.38M -$2.920M
YoY Change -2.6% -7.74% -51.25%
% of Operating Profit -30.44% 26.89%
Other Income/Expense, Net -$25.00K -$30.00K $20.00K
YoY Change -225.0% -103.0%
Pretax Income $6.498M $33.40M -$4.650M
YoY Change -239.74% -718.52% -56.98%
Income Tax $310.0K $1.140M $100.0K
% Of Pretax Income 4.77% 3.41%
Net Earnings $6.188M $32.26M -$4.750M
YoY Change -230.27% -719.41% -55.9%
Net Earnings / Revenue 16.38% 16.74% -21.48%
Basic Earnings Per Share $0.74
Diluted Earnings Per Share $130.8K $0.69 -$110.6K
COMMON SHARES
Basic Shares Outstanding 43.97M 43.77M
Diluted Shares Outstanding 46.64M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.492M $3.492M $1.300M
YoY Change 168.62% 168.62% -50.0%
Cash & Equivalents $3.492M $3.492M $1.348M
Short-Term Investments
Other Short-Term Assets $8.090M $8.090M $6.500M
YoY Change 24.46% 24.46% 44.44%
Inventory $94.14M $94.14M $44.46M
Prepaid Expenses
Receivables $14.22M $14.22M $9.806M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $119.9M $119.9M $62.14M
YoY Change 93.02% 93.15% -16.48%
LONG-TERM ASSETS
Property, Plant & Equipment $20.09M $26.90M $21.91M
YoY Change -8.29% -5.63% -30.88%
Goodwill $47.80M $47.80M
YoY Change 0.0%
Intangibles $20.36M $23.15M
YoY Change -12.06%
Long-Term Investments
YoY Change
Other Assets $710.0K $710.0K $85.00K
YoY Change 735.29% 610.0% -57.5%
Total Long-Term Assets $95.77M $95.77M $99.51M
YoY Change -3.76% -3.75% -5.95%
TOTAL ASSETS
Total Short-Term Assets $119.9M $119.9M $62.14M
Total Long-Term Assets $95.77M $95.77M $99.51M
Total Assets $215.7M $215.7M $161.6M
YoY Change 33.45% 33.49% -10.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.623M $9.623M $7.600M
YoY Change 26.62% 26.62% -26.21%
Accrued Expenses $13.99M $34.57M $5.329M
YoY Change 162.45% 66.19% -71.65%
Deferred Revenue
YoY Change
Short-Term Debt $15.00M $15.00M $2.000M
YoY Change 650.0%
Long-Term Debt Due $5.248M $5.248M $7.314M
YoY Change -28.25% -43.57% -56.98%
Total Short-Term Liabilities $64.44M $64.44M $37.77M
YoY Change 70.61% 70.47% -18.07%
LONG-TERM LIABILITIES
Long-Term Debt $73.15M $73.15M $77.98M
YoY Change -6.2% -6.22% -4.91%
Other Long-Term Liabilities $5.500M $5.500M $3.900M
YoY Change 41.03% 41.03% -31.58%
Total Long-Term Liabilities $73.15M $78.65M $77.98M
YoY Change -6.2% -3.97% -11.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.44M $64.44M $37.77M
Total Long-Term Liabilities $73.15M $78.65M $77.98M
Total Liabilities $144.8M $144.8M $121.0M
YoY Change 19.62% 19.65% -10.35%
SHAREHOLDERS EQUITY
Retained Earnings -$45.82M -$78.08M
YoY Change -41.32%
Common Stock $448.0K $433.0K
YoY Change 3.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $70.94M $70.94M $40.62M
YoY Change
Total Liabilities & Shareholders Equity $215.7M $215.7M $161.6M
YoY Change 33.45% 33.49% -10.29%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $6.188M $32.26M -$4.750M
YoY Change -230.27% -719.41% -55.9%
Depreciation, Depletion And Amortization $1.545M $3.387M $700.0K
YoY Change 120.71% 4.73% -57.83%
Cash From Operating Activities -$9.252M -$1.228M -$8.160M
YoY Change 13.38% -110.51% -280.13%
INVESTING ACTIVITIES
Capital Expenditures -$1.257M $1.922M -$470.0K
YoY Change 167.45% 30.75% 487.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.257M -$1.922M -$470.0K
YoY Change 167.45% 308.94% 487.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $201.0K
YoY Change 219.05%
Debt Paid & Issued, Net $5.252M
YoY Change 74.66%
Cash From Financing Activities 4.498M 5.294M 750.0K
YoY Change 499.73% -142.46% -104.54%
NET CHANGE
Cash From Operating Activities -9.252M -1.228M -8.160M
Cash From Investing Activities -1.257M -1.922M -470.0K
Cash From Financing Activities 4.498M 5.294M 750.0K
Net Change In Cash -6.011M 2.144M -7.880M
YoY Change -23.72% -271.25% -34.77%
FREE CASH FLOW
Cash From Operating Activities -$9.252M -$1.228M -$8.160M
Capital Expenditures -$1.257M $1.922M -$470.0K
Free Cash Flow -$7.995M -$3.150M -$7.690M
YoY Change 3.97% -130.83% -266.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000925528
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44758925
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43347887
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8100000
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
1-13412
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
CY2021Q4 us-gaap Goodwill
Goodwill
47803000
CY2020Q4 us-gaap Goodwill
Goodwill
47803000
CY2021 dei City Area Code
CityAreaCode
845
CY2021 dei Local Phone Number
LocalPhoneNumber
735-6000
CY2021 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2021 dei Trading Symbol
TradingSymbol
HDSN
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
141917622
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44810415
CY2021 dei Auditor Firm
AuditorFirmId
243
CY2021 dei Auditor Name
AuditorName
BDO USA, LLP
CY2021 dei Auditor Location
AuditorLocation
Stamford
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3492000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1348000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14223000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9806000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2020Q4 us-gaap Inventory Net
InventoryNet
44460000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8090000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6528000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
119949000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
62142000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21910000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20357000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23150000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6803000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6559000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
710000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
85000
CY2021Q4 us-gaap Assets
Assets
215715000
CY2020Q4 us-gaap Assets
Assets
161649000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9623000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
7644000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
30637000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
19417000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3931000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1394000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5248000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7314000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
15000000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64439000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37769000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1692000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1355000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5500000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3927000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
77976000
CY2021Q4 us-gaap Liabilities
Liabilities
144776000
CY2020Q4 us-gaap Liabilities
Liabilities
121027000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44758925
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43347887
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
448000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
433000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116312000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118269000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45821000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78080000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215715000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
161649000
CY2021 us-gaap Revenues
Revenues
192748000
CY2020 us-gaap Revenues
Revenues
147605000
CY2021 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
121084000
CY2020 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
112195000
CY2021 us-gaap Gross Profit
GrossProfit
71664000
CY2020 us-gaap Gross Profit
GrossProfit
35410000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26566000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26644000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2793000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2862000
CY2021 us-gaap Operating Expenses
OperatingExpenses
29359000
CY2020 us-gaap Operating Expenses
OperatingExpenses
29506000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
42305000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
5904000
CY2021 us-gaap Interest Expense
InterestExpense
11376000
CY2020 us-gaap Interest Expense
InterestExpense
12330000
CY2021 us-gaap Other Income
OtherIncome
2470000
CY2020 us-gaap Other Income
OtherIncome
1033000
CY2021 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-8906000
CY2020 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-11297000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33399000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5393000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1140000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-185000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
32259000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5208000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43765443
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42710381
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46640822
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42710381
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45111000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
621000
CY2020 us-gaap Profit Loss
ProfitLoss
-5208000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
201000
CY2021 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-2655000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
511000
CY2021 us-gaap Profit Loss
ProfitLoss
32259000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
32259000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5208000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3387000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3234000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2793000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2862000
CY2020 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
1000000
CY2021 hdsn Payment Protection Program Forgiveness
PaymentProtectionProgramForgiveness
-2475000
CY2021 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-2806000
CY2020 hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-3935000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
44000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
880000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1125000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1127000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
511000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
656000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
337000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
163000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4461000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2625000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
46878000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-18713000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2120000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2192000
CY2021 hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
4000
CY2020 hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
12000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
674000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-300000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5208000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43765443
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
CY2021 hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
CY2021 hdsn Allocation Allowance Received By Company
AllocationAllowanceReceivedByCompany
3
CY2021 hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16378000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-700000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1228000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11687000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1922000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1470000
CY2020 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1000000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1922000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-470000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
201000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
63000
CY2021 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-2655000
CY2020 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
2475000
CY2021 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
13000000
CY2020 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-12000000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5252000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3007000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5294000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12469000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2144000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1252000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2600000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
10157000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
11380000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
128000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-48000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">For the year ended December 31, 2021, one customer accounted for 10% of the Company’s revenues and at December 31, 2021, there were $3.1 million of outstanding receivables from this customer.For the year ended December 31, 2020, one customer accounted for 14% of the Company's revenues and at December 31, 2020, there were $2.9 million of outstanding receivables from this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8100000
CY2021 hdsn Cylinder Deposit Value
CylinderDepositValue
12300000
CY2020 hdsn Cylinder Deposit Value
CylinderDepositValue
11300000
CY2016Q3 hdsn Contract Term
ContractTerm
P5Y
CY2016Q3 hdsn Contract Renewal Term
ContractRenewalTerm
P5Y
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
192748000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
147605000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
29300000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q4 hdsn Net Operating Loss
NetOperatingLoss
16800000
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
32259000
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42710381
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2875379
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46640822
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42710381
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2583523
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5329515
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used including potential impact of COVID-19 uncertainties. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1600000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1600000
CY2020 hdsn Allowance For Doubtful Accounts Receivable Deductions And Other
AllowanceForDoubtfulAccountsReceivableDeductionsAndOther
7000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1597000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1597000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
44000
CY2021 hdsn Allowance For Doubtful Accounts Receivable Deductions And Other
AllowanceForDoubtfulAccountsReceivableDeductionsAndOther
-57000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1584000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
710000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
880000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
99828000
CY2020Q4 us-gaap Inventory Gross
InventoryGross
53593000
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
5684000
CY2020Q4 us-gaap Inventory Adjustments
InventoryAdjustments
9133000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2020Q4 us-gaap Inventory Net
InventoryNet
44460000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53854000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52284000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33761000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30374000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21910000
CY2021 us-gaap Depreciation
Depreciation
3400000
CY2020 us-gaap Depreciation
Depreciation
3200000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2371000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1642000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1605000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
903000
CY2021Q4 hdsn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2711000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9232000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2350000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6882000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5500000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3927000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6882000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6630000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y29D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M9D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0822
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0878
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
3100000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3000000.0
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33400000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5400000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
453000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-428000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
350000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
80000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
803000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-348000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
267000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
80000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
70000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
83000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
337000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
163000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1140000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-185000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.04
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2021 hdsn Effective Income Tax Rate Reconciliation Alternative Minimum Tax Credit And Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxCreditAndNetOperatingLossPercent
0
CY2020 hdsn Effective Income Tax Rate Reconciliation Alternative Minimum Tax Credit And Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxCreditAndNetOperatingLossPercent
0.08
CY2021 hdsn Effective Income Tax Rate Reconciliation Paycheck Protection Program Ppp Benefit Percent
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramPppBenefitPercent
0.02
CY2020 hdsn Effective Income Tax Rate Reconciliation Paycheck Protection Program Ppp Benefit Percent
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramPppBenefitPercent
0
CY2021 hdsn Effective Income Tax Rate Reconciliation Lobbying Percent
EffectiveIncomeTaxRateReconciliationLobbyingPercent
0
CY2020 hdsn Effective Income Tax Rate Reconciliation Lobbying Percent
EffectiveIncomeTaxRateReconciliationLobbyingPercent
-0.01
CY2021 hdsn Effective Income Tax Rate Reconciliation Meals And Entertainment Percent
EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
0
CY2020 hdsn Effective Income Tax Rate Reconciliation Meals And Entertainment Percent
EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
-0.01
CY2021 hdsn Effective Income Tax Rate Reconciliation Officer S Life Insurance Percent
EffectiveIncomeTaxRateReconciliationOfficerSLifeInsurancePercent
0
CY2020 hdsn Effective Income Tax Rate Reconciliation Officer S Life Insurance Percent
EffectiveIncomeTaxRateReconciliationOfficerSLifeInsurancePercent
0.04
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.12
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.03
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.03
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
29300000
CY2021 hdsn Annual Nol Limitation Percentage Of Tax Earnings
AnnualNolLimitationPercentageOfTaxEarnings
0.80
CY2021Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation And Amortization
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciationAndAmortization
-6365000
CY2020Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation And Amortization
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciationAndAmortization
-7424000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
398000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
324000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
977000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1408000
CY2021Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Non Qualified Stock Options
DeferredTaxAssetsTaxDeferredExpenseReservesAndNonQualifiedStockOptions
612000
CY2020Q4 hdsn Deferred Tax Assets Tax Deferred Expense Reserves And Non Qualified Stock Options
DeferredTaxAssetsTaxDeferredExpenseReservesAndNonQualifiedStockOptions
1219000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7270000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11963000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
0
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
0
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10381000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10114000
CY2021Q4 hdsn Deferred Tax Assets Deferred Bonus
DeferredTaxAssetsDeferredBonus
0
CY2020Q4 hdsn Deferred Tax Assets Deferred Bonus
DeferredTaxAssetsDeferredBonus
74000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
184000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15149000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19033000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1692000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1355000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q4 hdsn Net Operating Loss
NetOperatingLoss
16800000
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q4 us-gaap Goodwill
Goodwill
47800000
CY2020Q4 hdsn Capital Lease Obligation Current
CapitalLeaseObligationCurrent
4000
CY2021Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
5248000
CY2021Q4 us-gaap Goodwill
Goodwill
47800000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33397000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13040000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20357000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33397000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10247000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23150000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2800000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2800000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2800000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7000000.0
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13986000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5329000
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
12307000
CY2020Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
11338000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1378000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2702000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2966000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
30637000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
19417000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15000000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2020Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
2062000
CY2020Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
5248000
CY2021Q4 us-gaap Debt Current
DebtCurrent
20248000
CY2020Q4 us-gaap Debt Current
DebtCurrent
9314000
CY2021Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
74618000
CY2020Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
79867000
CY2020Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
413000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1473000
CY2020Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2304000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
77976000
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
93393000
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
87290000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
5248000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
74619000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
79867000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3100000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
3000000.0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000
CY2021Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
5069255
CY2021 hdsn Share Based Compensation Arrangement By Share Based Payment Award Percentage From Fair Market Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageFromFairMarketPrice
1.10
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7042377
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.01
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1967562
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.91
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
254700
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.11
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5329515
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.06
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
133257
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.02
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3076489
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.16
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
484254
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.82
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2604023
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.03
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2583523
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y10M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.00
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5329515
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.06
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
5261947
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y6M14D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.05
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
67568
CY2020 hdsn Share Based Compensation Arrangement By Sharebased Payment Award Options Non Vested Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedOutstandingWeightedAverageRemainingContractualTerms
P4Y8M15D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8900000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
700000
CY2020Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0.0
CY2021Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0.0
CY2021 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
1481858
CY2020 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
393952
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7088578
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
843893
CY2021 us-gaap Other Income
OtherIncome
2500000
CY2020Q3 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1000000

Files In Submission

Name View Source Status
0001410578-22-000491-index-headers.html Edgar Link pending
0001410578-22-000491-index.html Edgar Link pending
0001410578-22-000491.txt Edgar Link pending
0001410578-22-000491-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hdsn-20211231.xsd Edgar Link pending
hdsn-20211231x10k.htm Edgar Link pending
hdsn-20211231x10k_htm.xml Edgar Link completed
hdsn-20211231xex10d56.htm Edgar Link pending
hdsn-20211231xex21.htm Edgar Link pending
hdsn-20211231xex23d1.htm Edgar Link pending
hdsn-20211231xex31d1.htm Edgar Link pending
hdsn-20211231xex31d2.htm Edgar Link pending
hdsn-20211231xex32d1.htm Edgar Link pending
hdsn-20211231xex32d2.htm Edgar Link pending
hdsn-20211231_cal.xml Edgar Link unprocessable
hdsn-20211231_def.xml Edgar Link unprocessable
hdsn-20211231_lab.xml Edgar Link unprocessable
hdsn-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending